Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

artificial

artificial is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 11
News articles 0
Drug details — artificial
Class
—
Route
—
Patents
20
Programs
11
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

artificial is an FDA-listed pharmaceutical active ingredient.

Key facts

INN artificial

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. ION363-CS1 Phase 3 · IONIS PHARMACEUTICALS · Amyotrophic Lateral Sclerosis with Fused in Sarcoma mutation
  2. Anterior lamellar nanostructured artificial human cornea. Phase 2 · Lxo Ireland Designated · Severe Trophic Corneal Ulcers Refractory to Conventional Tre
  3. Bioengineered Artificial Mesenchimal Sheet (BAMS) Phase 2 · Lxo Ireland Designated · Venous Ulcer
  4. ION373-CS1 Phase 2 · IONIS PHARMACEUTICALS · Alexander Disease
  5. Hemodialysis with Polymethylmethacrylate Artificial Kidney Approved · Chinese Academy of · Uremia
  6. Accurate Prediction Artificial Intelligence Models Unknown · First People's Hospital · Prostate Cancer
  7. Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm Unknown · First People's Hospital · Ovarian Cancer
  8. Artificial intelligence Unknown · Hospital Authority · Internal Disease

Related patents

Browse patents

  1. US 12404275

    Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12304898

    Quinolyl-containing compound and pharmaceutical composition, and use thereof

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12269888

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12129258

    Diaryl macrocyclic compound and pharmaceutical composition, and use thereof

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12059443

    Method for treating cancer using dengue virus serotype 1 (DENV-1)

    Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11896623

    Visco-supplement compositions, and methods of use thereof

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11781247

    Variable epitope library compositions and methods of therapeutic and prophylactic use

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11667890

    Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11661459

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11491190

    Visco-supplement compositions, and methods of use thereof

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11389497

    Pharmaceutical composition for treating cancer

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11207687

    Artificial cells

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10945964

    Microencapsulated chitosan, methods of making and methods for the use thereof

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10881684

    Artificial invaplex formulated with deacylated lipopolysaccharide

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10878964

    Predictive control model for the artificial pancreas using past predictions

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10765705

    Visco-supplement compositions, and methods of use thereof

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10537611

    Methods of treating lung cancer

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10518074

    Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10517902

    Expandable amnion membrane for treating non-healing wounds

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10507284

    Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type I diabetes applications

    Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is artificial?

artificial is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.